Distinct Signal Transduction Pathways Mediate Nuclear Factor-κB Induction by IL-1β in Epithelial and Lymphoid Cells

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5264-5272

  Bonizzi, Giuseppina ^a   Piette, Jacques ^a   Merville, Marie Paule ^a   Bours, Vincent ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CERAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; PHOSPHOLIPASE A; SPHINGOMYELIN PHOSPHODIESTERASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; ENDOCYTOSIS; EPITHELIUM CELL; HUMAN; LYMPHOCYTE; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; CELLS, CULTURED; CERAMIDES; ENDOCYTOSIS; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-1; LYMPHOCYTES; MICE; NF-KAPPA B; PHOSPHOLIPASES A; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR CELLS, CULTURED;

EID: 0031304080     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation, and function of NF-κB. Annu. Rev. Biol. 10:405.
2. Miyamoto, S., and I. M. Verma. 1995. Rel/NF-κB/IκB story. Adv. Cancer Res. 66:255.
3. Baldwin, A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
4. Beg, A. A., and A. S. Baldwin. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:2064.
5. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485.
6. Traenckner, E. B.-M., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle. 1995. Phosphorylation of IκB-α on serines 32 and 36 controls IκB-a proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14:2876.
7. Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. J. Baldwin. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:3301.
8. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc. Natl. Acad. Sci. USA 90:2532.
9. Imbert, V., R. A. Rupec, A. Livolsi, H. L. Pahl, E. B.-M. Traenckner, C. Mueller-Dieckmann, D. Farahifar, B. Rossi, P. Auberger, P. A. Baeuerle, and J.-F. Peyron. 1996. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell 86:787.
10. Ballou, L. R., C. P. Chao, M. A. Holness, S. C. Barker, and R. Ragshow. 1992. Interleukin-1 -mediated PGE2 production and sphingomyelin metabolism. J. Biol. Chem. 267:20044.
11. Mathias, S., A. Younes, C.-C. Kan, I. Orlow, C. Joseph, and R. N. Kolesnick. 1993. Activation of sphingomyelin signal pathway in intact EL4 cells and in a cell-free system by IL-1β. Science 259:519.
12. Heller, R. A., and M. Krönke. 1994. Tumor necrosis factor-mediated signaling pathways. J. Cell Biol. 126:5.
13. Kolesnick, R., and D. W. Golde. 1994. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325.
14. Adam-Klages, S., D. Adam, K. Wiegmann, S. Struve, W. Kolanus, J. Schneider-Mergener, and M. Krönke. 1996. FAN, a novel WD-repeat protein couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86:937.
15. Wiegmann, K., S. Schütze, T. Machleidt, D. Witte, and M. Krönke. 1994. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005.
16. Müller, G., M. Ayoub, P. Storz, J. Rennecke, D. Fabbro, and K. Pfizenmaier. 1995. PKC ζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14:1961.
17. Machleidt, T., K. Wiegmann, T. Henkel, S. Schütze, P. Baeuerle, and M. Krönke. 1994. Sphingomyelinase activates proteolytic IκB-α degradation in a cell-free system. J. Biol. Chem. 269:13760.
18. Rivas, C. I., D. W. Golde, J. C. Vera, and R. N. Kolesnick. 1994. Involvement of the sphingomyelin pathway in autocrine tumor necrosis factor signaling for human immunodeficiency virus production in chronically infected HL-60 cells. Blood 8:2191.
19. Mathias, S., K. A. Dressler, and R. N. Kolesnick. 1991. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor α. Proc. Natl. Acad. Sci. USA 88:10009.
20. Finco, T. S., and A. S. J. Baldwin. 1993. κB site-dependent induction of gene expression by diverse inducers of nuclear factor κB requires Raf-1. J. Biol. Chem. 268:17676.
21. Raines, M. A., R. N. Kolesnick, and D. W. Golde. 1993. Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J. Biol. Chem. 268:14572.
22. Victor, I., P. Schwenger, W. Li, J. Schlessinger, and J. Vilcek. 1993. Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblast. J. Biol. Chem. 268: 18994.
23. Liu, J., S. Mathias, Z. Yang, and R. N. Kolesnick. 1994. Renaturation and tumor necrosis factor-α stimulation of a 97-kDa ceramide-activated protein kinase. J. Biol. Chem. 269:3047.
24. Belka, C., K. Wiegmann, D. Adam, R. Holland, M. Neuloh, F. Herrmann, M. Krönke, and M. A. Brach. 1995. Tumor necrosis factor (TNF)-α activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase. EMBO J. 14:1156.
25. Huwiler, A., J. Brunner, R. Hummel, M. Vervoordeldonk, S. Stabel, H. van den Bosch, and J. Pfeilschifter. 1996. Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc. Natl. Acad. Sci. USA 93:6959.
26. Lin, L.-L., M. Wartmann, A. Y. Lin, J. L. Knopf, A. Seth, and R. J. Davis. 1993. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72:269.
27. Los, M., H. Schenk, K. Hexel, P. A. Baeuerle, W. Dröge, and K. Schulze-Osthoff. 1995. IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14:3731.
28. Lozano, J., E. Berra, M. M. Municio, M. T. Diaz-Meco, I. Dominguez, L. Sanz, and J. Moscat. 1994. Protein kinase C ζ isoform is critical for κB-dependent promoter activation by sphingomyelinase. J. Biol. Chem. 269:19200.
29. Dbaibo, G. S., L. M. Obeid, and Y. A. Hannun. 1993. Tumor necrosis factor-α (TNF-α) signal transduction through ceramide. J. Biol. Chem. 268:17762.
30. Betts, J. C., A. B. Agranoff, G. J. Nabel, and J. A. Shayman. 1994. Dissociation of endogenous cellular ceramide from NF-κB activation. J. Biol. Chem. 269: 8455.
31. Johns, L. D., T. Sarr, and G. E. Ranges. 1994. Inhibition of ceramide pathway does not affect ability of TNF-α to activate nuclear factor-κB. J. Immunol. 152: 5877.
32. Schreck, R., P. Rieber, and P. A. Baeuerie. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:2247.
33. Schreck, R., K. Albermann, and P. A. Baeuerle. 1992. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radical Res. Commun. 17:221.
34. Schreck, R., B. Meier, D. N. Mannel, W. Droge, and P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175:1181.
35. Bonizzi, G., E. Dejardin, B. Piret, J. Piette, M-P. Merville, and V. Bours. 1996. IL-1β induces NF-κB in epithelial cells independently of the production of reactive oxygen intermediates. Eur. J. Biochem. 242:544.
36. Dejardin, E., G. Bonizzi, A. Bellahcène, V. Castronovo, M.-P. Merville, and V. Bours. 1995. Highly expressed p100/p52 (NFKB2) sequesters other NF-κB-related proteins in the cytoplasm of human breast cancer cells. Oncogene 11: 1835.
37. Franzoso, G., V. Bours, S. Park, M. Tomita-Yamaguchi, K. Kelly, and U. Siebenlist. 1992. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature 359:339.
38. Jaffrézou, J.-P., T. Levade, A. Bettaïeb, N. Andrieu, C. Bezombes, N. Maestre, S. Vermeersch, A. Rousse, and G. Laurent. 1996. Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J. 15:2417.
39. Levade, T., M.-C. Tempesta, and R. Salvayre. 1993. The in situ degradation of ceramide, a potential lipid mediator, is not completely impaired in Farber disease. FEBS Lett. 329:306.
40. Godfrey, R. W., W. J. Johnson, and S. T. Hoffstein. 1987. Recombinant tumor necrosis factor and interleukin-1 both stimulate human synovial cell arachidonic acid release and phospholipid metabolism. Biochim. Biophys. Res. Commun. 142: 235.
41. Feltenmark, S., G. Runarsson, P. Larsson, P.-J. Jakobsson, M. Björkholm, and H.-E. Claesson. 1995. Diverse expression of cytosolic phospholipase A2, 5-lipoxygenase and prostaglandin H synthase 2 in acute pre-B-lymphocytic leukemia cells. Br. J. Haematol. 90:585.
42. Sandstrom, P. A., B. Roberts, T. M. Folks, and T. M. Buttke. 1993. HIV gene expression enhances T cell susceptibility to hydrogen peroxide-induced apoptosis. AIDS Res. Hum. Retroviruses 9:1107.
43. Andrieu, N., R. Salvayre, J.-P. Jaffrézou, and T. Levade. 1995. Low temperatures and hypertonicity do not block cytokine-induced stimulation of the sphingomyelin pathway but inhibit nuclear factor-κB activation. J. Biol. Chem. 270:24518.
44. Lee, S., K. A. Felts, G. C. N. Parry, L. M. Armacost, and R. R. Cobb. 1997. Inhibition of 5-lipoxygenase blocks IL-1β-induced vascular adhesion molecule-1 gene expression in human endothelial cells. J. Immunol. 158:3401.
45. Gillard, J. W., A. W. Ford-Hutchinson, C. Chan, S. Charleson, D. Denis, A. Foster, R. Fortin, S. Leger, C. S. McFarlane, H. Morton, H. Piechuta, D. Riendeau, C. A. Rouzer, J. Rokach, R. Young, D. E. MacIntyre, L. Peterson, T. Bach, G. Eiermann, S. Hopple, J. Humes, L. Hupe, S. Luell, J. Metzger, R. Meurer, D. K. Miller, E. Opas, and S. Pacholok. 1989. L-663,536 (MK-886) (3-(1-(4-chlorobenzyl)-3-t-butyl-thio-isopropylindol-2-yl)-2,2-dimethylpropanoic acid), a novel, active leukotriene biosynthesis inhibitor. Can. J. Physiol. Pharmacol. 67:456.
46. Rouzer, C. A., A. W. Ford-Hutchinson, H. E. Morton, and J. W. Gillard. 1990. MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J. Biol. Chem. 265:1436.
47. Lewis, R. A., K. F. Austen, and R. J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway. N. Engl. J. Med. 323:645.
48. Harrison, K. A., and R. C. Murphy. 1995. Isoleukotrienes are biologically active free radical products of lipid peroxidation. J. Biol. Chem. 270:17273.
49. Schütze, S. K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Krönke. 1992. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765.
50. Reddy, S. A. G., M. M. Chaturvedi, B. G. Darnay, H. Chan, M. Higuchi, and B. B. Aggarwal. 1994. Reconstitution of nuclear factor κB activation induced by tumor necrosis factor requires membrane-associated components. J. Biol. Chem. 269:25369.
51. Zumbansen, M., and W. Stoffel. 1997. Tumor necrosis factor α activates NF-κB in acid sphingomyelinase-deficient mouse embryonic fibroblasts. J. Biol. Chem. 272:10904.
52. Hannun, Y. A. 1994. The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem. 269:3125.
53. Schütze, S., T. Machleidt, and M. Krönke. 1994. The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J. Leukocyte Biol. 56:533.
54. Segal, A. W., and A. Abo. 1993. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem. Sci. 18:43.
55. Perona, R., S. Montaner, L. Saniger, I. Sanchez-Perez, R. Bravo, and J. C. Lacal. 1997. Activation of the nuclear factor-κB by Rho, CDC42, and Rac-1 proteins. Genes Dev. 11:463.